Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68071-4897
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-4897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Effect Of Interacting Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv). (Venlafaxine Fig1)
This text appears to be referencing drug interactions and their effects on certain analytes in the body. It lists the drugs cimetane and aniatxine, veniatxine, and venistaxing, and provides PK Fold Change and 90% CI recommendations regarding dosage adjustments and caution when taking these drugs. The effects of some of the drugs are unknown, and caution and blood pressure monitoring are suggested in certain cases. The text also mentions changes relative to a reference value.*
Figure 2: Effect Of Venlafaxine On The Pharmacokinetics Interacting Drugs And Their Active Metabolites. (Venlafaxine Fig2)
Figure 3: Pharmacokinetics Of Venlafaxine And Its Metabolite O-desmethylvenlafaxine (odv) In Special Populations. (Venlafaxine Fig3)
Chemical Structure (Venlafaxine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.